BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $304,477 | -19.8% | 6,683 | -28.6% | 0.00% | 0.0% |
| Q1 2023 | $379,439 | -65.6% | 9,355 | -56.7% | 0.00% | -71.4% |
| Q4 2022 | $1,102,022 | -49.6% | 21,621 | -46.7% | 0.01% | -50.0% |
| Q3 2022 | $2,185,000 | -85.2% | 40,564 | -82.3% | 0.01% | -85.6% |
| Q2 2022 | $14,739,000 | -54.0% | 229,482 | -44.5% | 0.10% | -58.9% |
| Q1 2022 | $32,064,000 | -24.6% | 413,524 | -16.5% | 0.24% | -0.8% |
| Q4 2021 | $42,514,000 | -9.2% | 495,269 | -14.9% | 0.24% | -17.1% |
| Q3 2021 | $46,825,000 | +17.2% | 582,184 | +17.3% | 0.29% | +18.1% |
| Q2 2021 | $39,954,000 | -5.3% | 496,330 | -0.8% | 0.24% | -9.0% |
| Q1 2021 | $42,209,000 | +3.6% | 500,468 | -1.4% | 0.27% | +3.1% |
| Q4 2020 | $40,741,000 | -24.6% | 507,732 | -24.4% | 0.26% | -32.4% |
| Q3 2020 | $54,042,000 | -6.9% | 671,996 | -0.3% | 0.38% | -12.4% |
| Q2 2020 | $58,030,000 | +8.1% | 673,982 | +2.0% | 0.44% | -6.6% |
| Q1 2020 | $53,672,000 | -1.3% | 661,074 | +1.7% | 0.47% | +24.1% |
| Q4 2019 | $54,370,000 | -4.9% | 650,205 | -0.5% | 0.38% | -8.7% |
| Q3 2019 | $57,188,000 | +7.0% | 653,796 | +0.2% | 0.41% | +4.3% |
| Q2 2019 | $53,465,000 | +11.7% | 652,803 | +10.9% | 0.40% | -9.8% |
| Q1 2019 | $47,876,000 | +36.4% | 588,804 | +10.4% | 0.44% | +17.1% |
| Q4 2018 | $35,108,000 | +11.2% | 533,402 | +30.2% | 0.38% | -7.6% |
| Q3 2018 | $31,579,000 | +145.0% | 409,637 | +134.7% | 0.41% | +200.7% |
| Q2 2018 | $12,889,000 | +1001.6% | 174,544 | +870.3% | 0.14% | +938.5% |
| Q1 2018 | $1,170,000 | -1.3% | 17,988 | -1.9% | 0.01% | +8.3% |
| Q4 2017 | $1,185,000 | +42.1% | 18,332 | +38.0% | 0.01% | +33.3% |
| Q3 2017 | $834,000 | -9.2% | 13,286 | -12.5% | 0.01% | -10.0% |
| Q2 2017 | $919,000 | +5.6% | 15,178 | -9.5% | 0.01% | 0.0% |
| Q1 2017 | $870,000 | -6.2% | 16,778 | -19.9% | 0.01% | -9.1% |
| Q4 2016 | $928,000 | -7.7% | 20,940 | -0.8% | 0.01% | -8.3% |
| Q3 2016 | $1,005,000 | -7.0% | 21,102 | -11.7% | 0.01% | -14.3% |
| Q2 2016 | $1,081,000 | +7.3% | 23,886 | -2.5% | 0.01% | +7.7% |
| Q1 2016 | $1,007,000 | +8.3% | 24,506 | +0.5% | 0.01% | 0.0% |
| Q4 2015 | $930,000 | -24.0% | 24,376 | -34.6% | 0.01% | -27.8% |
| Q3 2015 | $1,224,000 | -78.6% | 37,247 | -54.5% | 0.02% | -76.6% |
| Q2 2015 | $5,719,000 | -61.6% | 81,776 | -62.4% | 0.08% | -61.9% |
| Q1 2015 | $14,910,000 | -85.2% | 217,661 | -84.1% | 0.20% | -85.6% |
| Q4 2014 | $100,625,000 | +6.2% | 1,372,967 | +4.0% | 1.41% | -0.4% |
| Q3 2014 | $94,708,000 | +8.2% | 1,319,600 | +9.0% | 1.41% | +6.1% |
| Q2 2014 | $87,517,000 | +3.2% | 1,210,464 | +5.1% | 1.33% | -2.1% |
| Q1 2014 | $84,783,000 | +68.0% | 1,152,265 | +58.8% | 1.36% | +64.3% |
| Q4 2013 | $50,459,000 | +15.8% | 725,510 | +9.4% | 0.83% | +5.6% |
| Q3 2013 | $43,558,000 | +0.4% | 663,079 | +5.8% | 0.78% | -4.5% |
| Q2 2013 | $43,399,000 | – | 626,516 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |